Werewolf Therapeutics, Inc.

HOWL

Financials

10-QQ2 ended 06/30/2607/31/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/27/26 10-QQ3 ended 09/30/2511/04/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report08/21/26 8-KCurrent report08/20/26 8-KCurrent report07/31/26 8-KCurrent report05/07/26 8-KCurrent report03/27/26

Prospectuses and Registrations

S-4/ARegistration (business combination, amended)10/26/26 S-4Registration (business combination)09/22/26 S-3Shelf registration05/08/25 S-8Registration of securities for employees05/08/25 424B5Prospectus supplement03/11/25

Proxies

DEF 14ADefinitive proxy04/28/25 DEFA14AAdditional proxy materials04/28/25 DEF 14ADefinitive proxy04/12/24 DEFA14AAdditional proxy materials04/12/24 DEF 14ADefinitive proxy04/27/23

Ownership

SC 13GBeneficial ownership09/21/26 Form 4Insider transaction07/08/26 144Proposed sale of securities07/06/26 144Proposed sale of securities07/06/26 144Proposed sale of securities07/06/26

Other

42542508/21/26 EFFECTRequest for effectiveness05/15/25 CORRESPCorrespondence with the SEC05/13/25 UPLOADLetter from the SEC05/12/25 ARSAnnual report to shareholders04/28/25